We are live on ! Find out more
CUE icon

Cue Biopharma
CUE

63 hedge funds and large institutions have $168M invested in Cue Biopharma in 2019 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 6

227% more capital invested

Capital invested by funds: $51.3M → $168M (+$116M)

144% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 9

40% more funds holding

Funds holding: 45 → 63 (+18)

0.63% more ownership

Funds ownership: 0.9% → 1.53% (+0.63%)

Holders
63
Holders Change
+18
Holders Change %
+40%
% of All Funds
1.24%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
22
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$19.6M
2
MP
Mangrove Partners
Connecticut
+$6.3M
3
CAG
Crestwood Advisors Group
Massachusetts
+$2.83M
4
PM
Precept Management
Texas
+$1.78M
5
BlackRock
BlackRock
New York
+$1.74M

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$422K
2
HSBC Holdings
HSBC Holdings
United Kingdom
-$397K
3
Millennium Management
Millennium Management
New York
-$117K
4
Citigroup
Citigroup
New York
-$108K
5
PGM
Parian Global Management
New York
-$93K
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$828K +$464K +1,476 +557%
Charles Schwab
27
Charles Schwab
California
$797K +$16K +51 +3%
Renaissance Technologies
28
Renaissance Technologies
New York
$689K +$454K +1,446 New
RCG
29
Rock Creek Group
District of Columbia
$595K -$52.5K -167 -12%
Wells Fargo
30
Wells Fargo
California
$496K +$45.2K +144 +16%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$485K – – –
HSBC Holdings
32
HSBC Holdings
United Kingdom
$473K -$397K -1,263 -56%
SO
33
STRS Ohio
Ohio
$447K – – –
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$384K +$5.97K +19 +2%
WHG
35
Westwood Holdings Group
Texas
$329K +$217K +690 New
Barclays
36
Barclays
United Kingdom
$317K +$59.7K +190 +40%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$298K +$83.9K +267 +74%
OAM
38
Oxford Asset Management
United Kingdom
$287K -$89.2K -284 -32%
LI
39
Leap Investments
Illinois
$241K +$159K +506 New
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$222K +$147K +467 New
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$214K -$11K -35 -7%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$205K +$135K +430 New
AIG
43
American International Group
New York
$198K +$1.26K +4 +1%
Bank of America
44
Bank of America
North Carolina
$194K -$9.11K -29 -7%
DAM
45
Doheny Asset Management
California
$193K +$127K +405 New
Federated Hermes
46
Federated Hermes
Pennsylvania
$174K +$115K +365 New
VOYA Investment Management
47
VOYA Investment Management
Georgia
$167K +$110K +350 New
MIM
48
MetLife Investment Management
New Jersey
$159K +$105K +334 New
Acadian Asset Management
49
Acadian Asset Management
Massachusetts
$141K +$93K +296 New
Deutsche Bank
50
Deutsche Bank
Germany
$114K +$15.4K +49 +26%
1
2
3

CUE Hedge Fund Activity: Q4 2019 in Review

63 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Cue Biopharma (CUE) for Q4 2019, worth a combined $168M — up 227% from $51.3M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CUE positions and 6 closed out — a net gain of 18 holders — while 22 added to existing stakes and 9 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $19.6M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $422K sold.

  • 63 institutional investors held Cue Biopharma (CUE) as of Q4 2019, up from 45 in Q3 2019.
  • Funds reported $168M of Cue Biopharma stock for Q4 2019, up 227% quarter-over-quarter.
  • 24 funds opened new Cue Biopharma positions in Q4 2019 and 6 closed out, a net change of +18 holders.
  • The largest Cue Biopharma buyer in Q4 2019 was Avoro Capital Advisors, an estimated $19.6M added.
  • The largest Cue Biopharma seller in Q4 2019 was Sphera Funds Management, an estimated $422K sold.

Based on aggregated 13F filings for Q4 2019.